Novel nanocarrier of miconazole based on chitosan-coated iron oxide nanoparticles as a nanotherapy to fight Candida biofilms

Arias, L. S., Pessan, J. P., de Souza Neto, F. N., Lima, B. H. R., de Camargo, E. R., Ramage, G. , Delbem, A. C. B. and Monteiro, D. R. (2020) Novel nanocarrier of miconazole based on chitosan-coated iron oxide nanoparticles as a nanotherapy to fight Candida biofilms. Colloids and Surfaces B: Biointerfaces, 192, 111080. (doi: 10.1016/j.colsurfb.2020.111080)

[img] Text
215098.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

6MB

Abstract

Overexposure of microorganisms to conventional drugs has led to resistant species that require new treatment strategies. This study prepared and characterized a nanocarrier of miconazole (MCZ) based on iron oxide nanoparticles (IONPs) functionalized with chitosan (CS), and tested its antifungal activity against biofilms of Candida albicans and Candida glabrata. IONPs-CS-MCZ nanocarrier was prepared by loading MCZ on CS-covered IONPs and characterized by physicochemical methods. Minimum inhibitory concentration (MIC) of the nanocarrier was determined by the microdilution method. Biofilms were developed (48 h) in microtiter plates and treated with MCZ-carrying nanocarrier at 31.2 and 78 μg/mL, in both the presence and absence of an external magnetic field (EMF). Biofilms were evaluated by total biomass, metabolic activity, cultivable cells (CFU), extracellular matrix components, scanning electron microscopy and confocal microscopy. Data were analyzed by two-way ANOVA and Holm-Sidak test (p < 0.05). A nanocarrier with diameter lower than 50 nm was obtained, presenting MIC values lower than those found for MCZ, and showing synergism for C. albicans and indifference for C. glabrata (fractional inhibitory concentration indexes of <0.12 and <0.53, respectively). IONPs-CS-MCZ did not affect total biomass and extracellular matrix. IONPs-CS-MCZ containing 78 μg/mL MCZ showed a superior antibiofilm effect to MCZ in reducing CFU and metabolism for single biofilms of C. albicans and dual-species biofilms. The EMF did not improve the nanocarrier effects. Microscopy confirmed the antibiofilm effect of the nanocarrier. In conclusion, IONPs-CS-MCZ was more effective than MCZ mainly against C. albicans planktonic cells and number of CFU and metabolism of the biofilms.

Item Type:Articles
Additional Information:This study was supported by the São Paulo Research Foundation (FAPESP, Grant# 2017/24416-2), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil; scholarship to the first author and Grant# 404721/2016-8) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Finance Code 001).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ramage, Professor Gordon
Authors: Arias, L. S., Pessan, J. P., de Souza Neto, F. N., Lima, B. H. R., de Camargo, E. R., Ramage, G., Delbem, A. C. B., and Monteiro, D. R.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Dental School
Journal Name:Colloids and Surfaces B: Biointerfaces
Publisher:Elsevier
ISSN:0927-7765
ISSN (Online):1873-4367
Published Online:25 April 2020
Copyright Holders:Copyright © 2020 Elsevier B.V.
First Published:First published in Colloids and Surfaces B: Biointerfaces 192: 111080
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record